Description

Join Dr. Ralph W. Moss and Ben Moss as they delve into the science of tomatoes and their potent component, lycopene. Uncover the groundbreaking research that positions lycopene as a significant agent against cancer. Discover the fascinating journey of lycopene from the humble tomato to its swift presence in our bloodstream, fueling our body's defense mechanisms. This episode is a compelling look into how nature equips us with powerful tools to combat disease, and offers practical insights on maximizing the benefits of tomatoes in our diet.

 

Articles Cited in this Episode:

Karppi J, Kurl S, Nurmi T, Rissanen TH, Pukkala E, Nyyssönen K. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann Epidemiol. 2009 Jul;19(7):512-8. doi: 10.1016/j.annepidem.2009.03.017. Epub 2009 May 13. PMID: 19443241.

https://www.sciencedirect.com/science/article/abs/pii/S1047279709001082?via%3Dihub

Kim JY, Paik JK, Kim OY, Park HW, Lee JH, Jang Y, Lee JH. Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis. 2011 Mar;215(1):189-95. doi: 10.1016/j.atherosclerosis.2010.11.036. Epub 2010 Dec 9. PMID: 21194693.

https://pubmed.ncbi.nlm.nih.gov/21194693/

Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, Giovannucci E. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014 Feb;106(2):djt430. doi: 10.1093/jnci/djt430. Epub 2014 Jan 24. PMID: 24463248; PMCID: PMC3952200.

https://pubmed.ncbi.nlm.nih.gov/24463248/

Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. Am J Clin Nutr. 2018 Nov 1;108(5):1069-1091. doi: 10.1093/ajcn/nqy097. PMID: 30475962; PMCID: PMC6250988.

https://pubmed.ncbi.nlm.nih.gov/30475962/

Ansari MS, Gupta NP. Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer. Urol Oncol. 2004 Sep-Oct;22(5):415-20. doi: 10.1016/j.urolonc.2004.05.009. PMID: 15464923.

https://pubmed.ncbi.nlm.nih.gov/15464923/

Thanks for listening!